Bio-Thera Solutions, Ltd announced that its partner Biogen recently received notification from the United States Food and Drug Administration on the approval of TOFIDENCE intravenous formulation, a biosimilar monoclonal antibody referencing ACTEMRA.
Bio-Thera Solutions, Ltd announced that its partner Biogen recently received notification from the United States Food and Drug Administration on the approval of TOFIDENCE intravenous formulation, a biosimilar monoclonal antibody referencing ACTEMRA.